Myeloid/natural killer cell precursor acute leukemia with multiple subcutaneous nodules as the initial presentation: a case report and literature review.
Myeloid/natural killer (NK) cell precursor acute leukemia is a rare neoplasm, which is characterized by high incidence of extramedullary infiltration, especially in the mediastinum and lymph nodes, an aggressive course and poor prognosis. As coexpressing myeloid and NK-cell antigens, myeloid/NK-cell precursor acute leukemia (MNKL) may pose diagnostic difficulty. Because the developmental pathway of normal NK cells is not well understood, neoplams of NK-cell origin are not clearly identified. To our knowledge, there have been only about 30 cases with this disease published previously. In the current paper, we present a case of a 21-year-old male patient whose initial presentation showed numerous subcutaneous nodules without bone marrow involvement. A diagnosis of MNKL was finally made by skin biopsy, bone marrow immunohistochemistry and immunophenotypic analysis. Although bone marrow achieved complete remission using DA chemotherapeutic regimen, the skin nodules did not regress. However, FLAG chemotherapeutic regimen, including fludarabine, cytarabine and G-CSF, was effective for both bone marrow and skin involvement. To the best of our knowledge, this study is the first to describe the effect of FLAG regimen for the treatment of this disease, indicating that it may be effective against the skin involvement of MNKL.
Ma
Yan
Y
Department of Hematology, Huashan Hospital, Fudan University, No.12 Central Urmuqi Road, 200040, Shanghai, China.
Chen
Bobin
B
Department of Hematology, Huashan Hospital, Fudan University, No.12 Central Urmuqi Road, 200040, Shanghai, China.
Xu
Xiaoping
X
Department of Hematology, Huashan Hospital, Fudan University, No.12 Central Urmuqi Road, 200040, Shanghai, China. xpxu1111@163.com.
Lin
Guowei
G
Department of Hematology, Huashan Hospital, Fudan University, No.12 Central Urmuqi Road, 200040, Shanghai, China.
D001853:Bone Marrow / Q000473:pathology; D003937:Diagnosis, Differential; D006801:Humans; D007694:Killer Cells, Natural / Q000473:pathology*; D007951:Leukemia, Myeloid / Q000473:pathology*; D017254:Leukemic Infiltration; D008297:Male; D022423:Myeloid Cells / Q000473:pathology*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000473:pathology*; D012867:Skin / Q000473:pathology*; D055815:Young Adult